Simon Higgins

Simon Higgins is currently the Business Unit Head for Neuroscience and Rare Disease in the ANZ region at Ipsen, a position held since April 2023. Prior to this role, Simon served as the Director of Market Access & Public Affairs at Commercial Eyes Pty Ltd. Simon's extensive experience includes leadership positions at Maxx Pharma Pty Ltd, Bristol-Myers Squibb, Pfizer, Hospira, and Boehringer Ingelheim, focusing on market access, pricing, policy, and commercial operations. Educational qualifications include an MBA from Melbourne Business School, a Master of Public Health in Health Economics from the University of Melbourne, and a Bachelor of Applied Science in Physiotherapy from La Trobe University.